Angiogenesis signaling in endometriosis: Molecules, diagnosis and treatment (Review)

Mol Med Rep. 2024 Mar;29(3):43. doi: 10.3892/mmr.2024.13167. Epub 2024 Jan 19.ABSTRACTEndometriosis (EM) is one of the most common diseases among women of reproductive age. The etiology and pathogenesis of EM remain unclear and therefore there is a lack of effective treatment measures, which affects physical and mental health, as well as the quality of life of patients with EM. Angiogenesis has become a hotspot for research on the pathogenesis of EM; the role of angiogenesis‑related serological markers and anti‑angiogenic therapy in the diagnosis and treatment of EM is promising for early diagnosis and treatment of EM. Angiogenesis in EM is subject to complex regulation by hormones, immunity and associated cytokines. Therefore, novel targets for angiogenesis therapy are also being discovered and developed. The present review summarized the pathological mechanisms of angiogenesis and the value of relevant markers in pathogenesis and diagnosis of EM, along with the status of research on anti‑angiogenic drugs in the treatment of EM. The role of angiogenesis in EM provides an important reference for treatment and diagnosis, but there is no uniform non‑invasive diagnostic marker and proven strategy for anti‑angiogenesis.PMID:38240108 | PMC:PMC10828998 | DOI:10.3892/mmr.2024.13167
Source: Molecular Medicine Reports - Category: Molecular Biology Authors: Source Type: research